DETROIT – Study into hydroxychloroquine as a treatment for the coronavirus (COVID-19) has constantly evolved throughout the pandemic, and now, researchers are studying whether the drug can prevent the infection from developing in someone who was exposed to the virus. RECENTLY: New COVID-19 studies raise flags, under auditPreviously published studies have primarily focused on using hydroxychloroquine to treat COVID-19 after someone had already developed the infection, and to date, they have not been conclusive regarding benefit. A new study moved up the process and examined whether hydroxychloroquine can prevent an infection after someone is exposed. ResultsIn the end, there was no significant difference in the number of COVID-19 infections after exposure, and it was concluded that hydroxychloroquine was not found to have a benefit in preventing the development of COVID-19 after exposure. Henry Ford Hospital is still enrolling for the WHIP COVID-19 study of front line workers.

Can hydroxychloroquine prevent infection after exposure to coronavirus (COVID-19)? Published: June 4, 2020, 4:28 pmStudy into hydroxychloroquine as a treatment for the coronavirus (COVID-19) has constantly evolved throughout the pandemic, and now, researchers are studying whether the drug can prevent the infection from developing in someone who was exposed to the virus.

DETROIT – There are two drugs at the center of the battle against the coronavirus (COVID-19): hydroxychloroquine and remdesivir. Here’s what we know about the research into both. Remdesivir shipmentThere’s also an update on the distribution of remdesivir to patients in the state of Michigan. On Saturday, state officials received 1,600 vials of the drug from the United States supply, enough for about 145 critically ill patients. The state is prioritizing distribution to communities with the highest death rates and most patients with COVID-19 on ventilators.

What we know about 2 drugs at center of coronavirus (COVID-19) vaccine researchPublished: May 14, 2020, 4:09 pmThere are two drugs at the center of the battle against the coronavirus (COVID-19): hydroxychloroquine and remdesivir. Here’s what we know about the research into both.